Christina K. Tripsas

Pulmonary Medicine

757 Westwood Plz
Los Angeles, CA 90095

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Lipids in endothelial-to-mesenchymal transition.

Lipids in endothelial-to-mesenchymal transition.

Journal: Current opinion in lipidology

Published: August 13, 2026

Development of a Stereolithography 3D Printing-Based Micropatterning Method to Study Endothelial-to-Mesenchymal Transition Mechanobiology.

Development of a Stereolithography 3D Printing-Based Micropatterning Method to Study Endothelial-to-Mesenchymal Transition Mechanobiology.

Journal: Annals of biomedical engineering

Published: August 19, 2025

Prospective, Multicenter Clinical Trial of Everolimus as Primary Therapy in Waldenstrom Macroglobulinemia (WMCTG 09-214).

Prospective, Multicenter Clinical Trial of Everolimus as Primary Therapy in Waldenstrom Macroglobulinemia (WMCTG 09-214).

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: July 29, 2016

Ibrutinib in previously treated Waldenström's macroglobulinemia.

Ibrutinib in previously treated Waldenström's macroglobulinemia.

Journal: The New England journal of medicine

Published: April 09, 2015

Carfilzomib, rituximab, and dexamethasone (CaRD) treatment offers a neuropathy-sparing approach for treating Waldenström's macroglobulinemia.

Carfilzomib, rituximab, and dexamethasone (CaRD) treatment offers a neuropathy-sparing approach for treating Waldenström's macroglobulinemia.

Journal: Blood

Published: May 27, 2014

The genomic landscape of Waldenstrom macroglobulinemia is characterized by highly recurring MYD88 and WHIM-like CXCR4 mutations, and small somatic deletions associated with B-cell lymphomagenesis.

The genomic landscape of Waldenstrom macroglobulinemia is characterized by highly recurring MYD88 and WHIM-like CXCR4 mutations, and small somatic deletions associated with B-cell lymphomagenesis.

Journal: Blood

Published: December 25, 2013

Detection of MYD88 L265P in peripheral blood of patients with Waldenström's Macroglobulinemia and IgM monoclonal gammopathy of undetermined significance.

Detection of MYD88 L265P in peripheral blood of patients with Waldenström's Macroglobulinemia and IgM monoclonal gammopathy of undetermined significance.

Journal: Leukemia

Published: December 02, 2013

Comparative response assessment by serum immunoglobulin M M-protein and total serum immunoglobulin M after treatment of patients with Waldenström macroglobulinemia.

Comparative response assessment by serum immunoglobulin M M-protein and total serum immunoglobulin M after treatment of patients with Waldenström macroglobulinemia.

Journal: Clinical lymphoma, myeloma & leukemia

Published: May 14, 2013

Challenges with serum protein electrophoresis in assessing progression and clinical response in patients with Waldenström macroglobulinemia.

Challenges with serum protein electrophoresis in assessing progression and clinical response in patients with Waldenström macroglobulinemia.

Journal: Clinical lymphoma, myeloma & leukemia

Published: May 14, 2013

Patients with Waldenström macroglobulinemia commonly present with iron deficiency and those with severely depressed transferrin saturation levels show response to parenteral iron administration.

Patients with Waldenström macroglobulinemia commonly present with iron deficiency and those with severely depressed transferrin saturation levels show response to parenteral iron administration.

Journal: Clinical lymphoma, myeloma & leukemia

Published: March 26, 2013

MYD88 L265P in Waldenström macroglobulinemia, immunoglobulin M monoclonal gammopathy, and other B-cell lymphoproliferative disorders using conventional and quantitative allele-specific polymerase chain reaction.

MYD88 L265P in Waldenström macroglobulinemia, immunoglobulin M monoclonal gammopathy, and other B-cell lymphoproliferative disorders using conventional and quantitative allele-specific polymerase chain reaction.

Journal: Blood

Published: January 17, 2013

MYD88 L265P somatic mutation in Waldenström's macroglobulinemia.

MYD88 L265P somatic mutation in Waldenström's macroglobulinemia.

Journal: The New England journal of medicine

Published: August 31, 2012

Showing 1-12 of 13

Last Updated: 09/26/2026